Sunshine Biopharma (SBFMW) EBITDA Margin Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFMW) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 304.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -157.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -650.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,080.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 7,720.00 |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 152.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -17,785.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -583.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 118,171.00 |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -585.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -585.00 |
| Dec 31, 2025 | 1,092.00 |
| Sep 30, 2025 | -1,167.00 |
| Jun 30, 2025 | 700.00 |
| Mar 31, 2025 | 1,127.00 |
| Dec 31, 2024 | -2,302.00 |
| Sep 30, 2024 | 1,456.00 |
| Jun 30, 2024 | -692.00 |
| Mar 31, 2024 | 1,032.00 |
| Dec 31, 2023 | 58,077.00 |
| Sep 30, 2023 | 111,240.00 |
| Jun 30, 2023 | 35,955.00 |
| Mar 31, 2023 | 97,260.00 |
| Dec 31, 2022 | -136,775.00 |
| Sep 30, 2022 | 689,899.00 |
| Jun 30, 2022 | 509,087.00 |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 464,105.00 |
| Sep 30, 2021 | -395,578.00 |
| Jun 30, 2021 | 53,077.00 |